Hyperparathyroidism And Stroke: Is There A Link?

Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood, a condition known as hypercalcaemia. While hyperparathyroidism can be asymptomatic, it can also cause a range of symptoms, including nausea, vomiting, loss of appetite, and confusion. If left untreated, hyperparathyroidism can lead to serious complications, including osteoporosis, kidney stones, and high blood pressure. Importantly, high blood calcium levels have been associated with cardiovascular conditions such as endothelial dysfunction, vascular stiffness, and calcification. Several studies have indicated a link between elevated PTH levels and an increased risk of stroke.

Hyperparathyroidism and osteoporosis

Hyperparathyroidism (HPT) is a condition where the parathyroid glands release too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood, known as hypercalcaemia.

The parathyroid glands control how much calcium is in your bones and blood. When they aren't working correctly, calcium levels can become imbalanced. Since calcium is essential for good bone health, this puts you at a higher risk of osteoporosis.

Osteoporosis is a disease characterised by brittle bones and a higher potential for fractures. There is no cure, but treatments are available to slow bone loss and reduce fracture risk.

If the parathyroid glands are producing too much parathyroid hormone, calcium will be released from bone stores. This increases the rate of bone turnover (the cycle of bone breakdown and renewal) and can lead to osteoporosis and broken bones.

In some cases, primary hyperparathyroidism may only be discovered after a broken bone has occurred. If hyperparathyroidism is present, treating it is the priority to eliminate the primary cause of bone loss.

A DEXA scan can help detect bone loss, and in some circumstances, the bone density may be measured at the forearm to provide additional information.

If you have hyperparathyroidism, your doctor may recommend surgery to remove the affected parathyroid gland(s). After successful treatment, bone density levels are likely to improve. Lifestyle changes, such as a diet rich in vitamin D and calcium, can also help keep bones strong and healthy.

Hyperparathyroidism and kidney stones

Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood, a condition known as hypercalcaemia. Hyperparathyroidism can be caused by growths or enlarged glands (primary hyperparathyroidism) or by kidney disease or low calcium levels (secondary hyperparathyroidism).

Hyperparathyroidism can cause kidney stones. When the parathyroid glands malfunction, they can produce excess PTH, which leads to unregulated levels of calcium in the blood. The kidneys are responsible for filtering out this excess calcium, but in people with hyperparathyroidism, the kidneys are constantly filtering out high levels of calcium. This extra calcium in the kidneys and urine can lead to the development of kidney stones.

The risk of renal stone events is increased in people with primary hyperparathyroidism, and surgery to remove the affected parathyroid gland(s) can help reduce this risk. In fact, surgery has been shown to decrease the risk of renal stone events by 8.3% compared to controls. However, it is important to note that the risk of renal stone events may remain elevated for up to 10 years after surgery.

In addition to surgery, other treatments for hyperparathyroidism may include medications and lifestyle changes. For kidney stones specifically, drinking water and using pain relievers may help pass the stones naturally. In cases of large kidney stones, sound waves may be used to break them up, or surgery or a scope may be used to remove them.

Symptoms and Complications

Hyperparathyroidism can cause a variety of symptoms, including increased thirst and frequent urination, nausea, loss of appetite, and loss of concentration. If left untreated, hyperparathyroidism can lead to serious complications, including osteoporosis, kidney stones, kidney damage or failure, stomach ulcers, and pancreatitis. In very severe cases, high calcium levels can lead to rapid kidney failure, loss of consciousness, coma, or life-threatening heart rhythm abnormalities.

Hyperparathyroidism and cardiovascular disease

Hyperparathyroidism is a condition where the parathyroid glands, located in the neck near the thyroid gland, produce too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood (hypercalcaemia), which can have serious health consequences if left untreated.

Cardiovascular complications

High levels of calcium in the blood can lead to an increased risk of cardiovascular disease, including heart disease, high blood pressure, and certain types of heart conditions. The exact cause-and-effect link between hyperparathyroidism and cardiovascular disease is not yet fully understood and requires further research. However, it is known that elevated PTH levels can affect the cardiovascular system by increasing blood pressure and cardiac contractility, leading to fibrosis, apoptosis, and hypertrophy in the cardiomyocytes of the left ventricle and vascular smooth muscle cells.

Additionally, elevated PTH levels have been associated with various cardiovascular conditions such as endothelial dysfunction, vascular stiffness, calcification, increased aortic pulse pressure, reduced great artery elasticity, coronary microvascular dysfunction, and hypertension. PTH may also affect the cardiovascular system by stimulating cytokine release from lymphocytes and vascular smooth muscle cells.

Studies have also shown that increased PTH levels are associated with inflammation markers, which are now considered risk factors for cardiovascular disease. Furthermore, there is evidence that reducing PTH levels through treatments such as parathyroidectomy, renal transplantation, or calcimimetic agents can decrease the incidence of cardiovascular disorders, suggesting a causal role for PTH in the development of these conditions.

Other health complications

In addition to the cardiovascular risks, hyperparathyroidism can also lead to other serious health complications, including:

• Osteoporosis and bone fractures: High PTH levels cause bones to release more calcium than normal, leading to weakened bones that are more susceptible to fractures.
• Kidney stones and damage: Excess calcium in the blood can lead to the formation of kidney stones and, in severe cases, rapid kidney failure.
• Stomach ulcers: Untreated hyperparathyroidism can lead to gastric or peptic ulcers.
• Pancreatitis: Inflammation of the pancreas can occur as a result of high calcium levels.
• Severe cases: In very severe and untreated cases, hyperparathyroidism can lead to loss of consciousness, coma, or life-threatening heart rhythm abnormalities.

Diagnosis and treatment

Hyperparathyroidism is typically diagnosed through blood tests that reveal high levels of PTH and calcium. Imaging techniques such as ultrasounds, CT scans, or DEXA scans (bone density X-rays) may also be used to detect calcium deposits, bone loss, or kidney stones. Treatment options include surgery to remove the affected parathyroid gland(s), medication to control calcium levels, and lifestyle changes such as increasing fluid intake and avoiding certain medications.

Hyperparathyroidism and high blood pressure

Hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH). This can cause high levels of calcium in the blood, a condition known as hypercalcaemia. Hyperparathyroidism can be primary, secondary, or tertiary. Primary hyperparathyroidism is caused by growths or enlarged glands, while secondary hyperparathyroidism is caused by conditions such as kidney disease or low calcium levels. Tertiary hyperparathyroidism occurs when secondary hyperparathyroidism persists and becomes resistant to treatment.

High blood pressure, or hypertension, is a common complication of hyperparathyroidism, affecting between 40% to 80% of patients. The exact mechanisms linking hyperparathyroidism and hypertension are not fully understood, but several factors may be involved. Firstly, PTH can increase blood pressure by raising intracellular calcium levels and activating the renin-angiotensin-aldosterone system, a major regulator of blood pressure. Secondly, hyperparathyroidism can lead to hypercalcaemia, which has been associated with increased vascular responsiveness to vasoconstrictor stimuli and activation of signalling pathways that promote tissue fibrosis and arterial stiffening. Thirdly, PTH has been shown to have direct effects on the vascular endothelium, impairing its function and leading to endothelial dysfunction, which is a hallmark of hypertension. Finally, hyperparathyroidism is often associated with other metabolic complications such as diabetes, metabolic syndrome, and obesity, which are independent risk factors for hypertension.

The relationship between hyperparathyroidism and hypertension has important clinical implications. Untreated hyperparathyroidism is associated with increased cardiovascular mortality, and hypertension is a major risk factor for cardiovascular disease. Therefore, managing hypertension in patients with hyperparathyroidism is crucial. However, the impact of parathyroidectomy, the surgical removal of the parathyroid gland, on hypertension in these patients is inconclusive. Some studies report a decrease in blood pressure after parathyroidectomy, while others find no significant changes. The variability in these results may be due to differences in study populations, follow-up durations, and definitions of hypertension.

In summary, hyperparathyroidism and hypertension are closely linked, and the elevated PTH levels in hyperparathyroidism can contribute to increased blood pressure through various mechanisms. Managing hypertension in patients with hyperparathyroidism is essential to reduce the risk of cardiovascular complications. Further research is needed to fully understand the relationship between hyperparathyroidism and hypertension and to optimize treatment strategies for these patients.

Hyperparathyroidism and stroke risk

Hyperparathyroidism is a condition where the parathyroid glands (located in the neck) produce too much parathyroid hormone (PTH). This can lead to high levels of calcium in the blood (hypercalcaemia). There are two types of hyperparathyroidism: primary and secondary. Primary hyperparathyroidism is caused by a problem with one or more of the parathyroid glands, such as a benign tumour called an adenoma. Secondary hyperparathyroidism is when the glands are functioning correctly, but another condition, such as kidney failure, lowers calcium levels, causing the body to produce extra PTH.

Hyperparathyroidism and Increased Stroke Risk

High levels of PTH can lead to increased blood pressure and cardiac contractility, resulting in fibrosis, apoptosis, and hypertrophy in the cardiomyocytes of the left ventricle and vascular smooth muscle cells. This can lead to various cardiovascular conditions such as endothelial dysfunction, vascular stiffness, and calcification, which can increase the risk of stroke. Additionally, increased PTH levels may affect the cardiovascular system by stimulating cytokine release from lymphocytes and vascular smooth muscle cells.

Several studies have indicated a link between elevated PTH levels and stroke risk. For example, a study by Sato et al. found an association between elevated PTH levels and stroke in patients with hypercalcemia, with an incidence of 7.1% in patients with primary hyperparathyroidism. Another study by Boström and Alveryd also suggested a link between hyperparathyroidism and stroke.

Factors Affecting Stroke Risk in Hyperparathyroidism

The risk of stroke in individuals with hyperparathyroidism may be influenced by various factors, including age, sex, and vitamin D levels. Primary hyperparathyroidism is most common in people between the ages of 50 and 60, and women are affected more often than men. Vitamin D deficiency is also a contributing factor, as it can lead to secondary hyperparathyroidism by reducing calcium levels in the blood.

Treatment and Management

The treatment for hyperparathyroidism depends on the type and severity of the condition. Surgery to remove the affected parathyroid gland(s) is usually recommended, especially if the patient is experiencing symptoms or complications. In some cases, medication may be prescribed to control calcium levels, such as bisphosphonates or cinacalcet. However, surgery is the only definitive cure for hyperparathyroidism.

Hyperparathyroidism can increase the risk of stroke by affecting cardiovascular health and blood pressure. Early diagnosis and treatment are important to prevent serious complications, including stroke. Further research is needed to fully understand the relationship between hyperparathyroidism and stroke risk.

Frequently asked questions